Navigation Links
Cystic Fibrosis Services Pharmacy Celebrates 20th Anniversary
Date:12/17/2008

Organization Has Filled More Than 1 Million Prescriptions

BETHESDA, Md., Dec. 17 /PRNewswire-USNewswire/ -- Cystic Fibrosis Services, Inc., a wholly owned subsidiary of the Cystic Fibrosis Foundation, today announced its 20th anniversary of providing quality pharmacy services to the cystic fibrosis (CF) community nationwide.

The organization was founded in 1988 with one patient, one prescription and a mission to improve access to specialty medications for people with CF. It met an untapped need and had 1,300 customers within six months. Today, the pharmacy has filled more than one million prescriptions and provides services to nearly 8,000 customers - almost one-third of the entire CF population in the United States.

"The CF Services Pharmacy has a 20-year track record of advocating for people with cystic fibrosis and removing barriers that stand in the way of people receiving the drugs and therapies they need to stay healthy," said Robert J. Beall, Ph.D., president and CEO of the Cystic Fibrosis Foundation.

In addition to competitively priced medications, CF Services provides many free services unavailable at other pharmacies. These include help with insurance reimbursement, monthly billing (rather than upfront payment), specialty supplies and equipment at no charge, and financial assistance for those in need. The pharmacy provides more than $1 million in assistance and support annually to customers and the CF community.

"We are honored to have helped and served so many people with cystic fibrosis over the past two decades," said Dan Klein, Vice President and general manager of CF Services. "As important new CF therapies become available in the coming years, we are poised to tackle whatever obstacles stand in the way of patients receiving the best CF drugs available."

CF Services has also played an important role in helping pharmaceutical companies set up patient assistance programs, and in funding patient education programs at CF Foundation-accredited care centers and fundraising chapters.

CF is a life-threatening genetic disease that affects approximately 30,000 people in the United States. It causes the body to produce abnormally thick mucus that leads to debilitating lung infections and digestion complications. When the CF Foundation was created in 1955, few children lived to attend elementary school. Today, because of research and care supported by the CF Foundation, the median age of survival for a person with CF is now age 37.

About CF Services and the Cystic Fibrosis Foundation

CF Services Inc., a wholly owned subsidiary of the Cystic Fibrosis Foundation, was established in 1988 as a specialty pharmacy in response to CF patients' need for quality pharmacy services. Today, CF Services continues this mission. CF Services understands that CF is complicated and getting your medication shouldn't be! For more information, visit the CF Services Web site at www.CFServicesPharmacy.com.

The Cystic Fibrosis Foundation is the leading organization in the United States devoted to curing and controlling cystic fibrosis. Headquartered in Bethesda, MD, the Foundation has more than 80 chapters and branch offices throughout the country and supports and accredits a nationwide network of 115 care centers. For more information, visit www.cff.org.


'/>"/>
SOURCE Cystic Fibrosis Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Scientists Spot Key to Cystic Fibrosis Infections
2. Intervention in infants with cystic fibrosis key to slowing progression
3. Estrogen May Explain Why Women With Cystic Fibrosis Suffer More
4. Cystic Fibrosis Foundation Establishes Landmark Patient Assistance Foundation
5. Vitamin D Guidelines Too Low for Cystic Fibrosis Kids
6. Children with cystic fibrosis not well covered by guidelines for vitamin D needs
7. Mucous breakthrough in mice holds promise for cystic fibrosis
8. Five States Step Up Efforts to Screen Newborns for Cystic Fibrosis
9. Cystic Fibrosis Foundation Hosts Quality Improvement Summit - Caregivers from 15 States and Canada Gather in Hartford for Intensive Learning
10. GREAT STRIDES Walks for Cystic Fibrosis Slated for 47 States This Weekend
11. Cystic Fibrosis Foundation President Rings Bell to Close New York Stock Exchange
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... The Wharton School’s Aresty Institute ... as a kick-off to the fifth annual CEO Connection Mid-Market Convention. , ... of Pennsylvania campus, followed by the two-day convention, which will target C-suite executives ...
(Date:6/28/2017)... Santa Clara, CA (PRWEB) , ... June 28, 2017 , ... ... is hosting a free AFM Luncheon for all SEMICONWest attendees and Park ... The luncheon will feature talks from Dr. Sang-il Park, Chairman & CEO of Park ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... and financial planning assistance to clients in southern Montana, is announcing a focused ... Zoo Montana. , The outreach programs offered by Zoo Montana provide students with ...
(Date:6/28/2017)... ... June 28, 2017 , ... Designers Insurance Agency, a ... northern Virginia and DC, is announcing a cooperative charity event in conjunction with ... other disorders that lead to memory impairment. , The Insight Memory Care Center ...
(Date:6/27/2017)... (PRWEB) , ... June 27, 2017 , ... ... announced the appointment of Mike Finnegan to the position of Executive Vice President, ... of experience in healthcare technology, telehealth and medical device sales leadership. He has ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... The Bio Supply Management Alliance (BSMA) has ... and the Biomedical Manufacturing Network to advance ... California by providing a platform for ... workforce development. The primary focus of this alliance is ... well as small and mid-sized biomedical companies. ...
(Date:6/13/2017)... , June 13, 2017 Zimmer Biomet Holdings, ... healthcare, today announced that the U.S. Food and Drug Administration ... June 3, 2015 relating to its Zhejiang, China ... "The successful clearance of the Warning ... manufacturing facility is a measure of the progress we ...
(Date:6/11/2017)... 2017  Eli Lilly and Company (NYSE: LLY ... studies of galcanezumab, an investigational treatment for the prevention ... several key secondary endpoints for galcanezumab compared to placebo ... (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented today at ... Boston . "The ...
Breaking Medicine Technology: